Tissue-localized immune responses in people with cystic fibrosis and respiratory nontuberculous mycobacteria infection
Nontuberculous mycobacteria (NTM) are an increasingly common cause of respiratory infection in people with cystic fibrosis (PwCF). Relative to those with no history of NTM infection (CF-NTMNEG), PwCF and a history of NTM infection (CF-NTMPOS) are more likely to develop severe lung disease and experi...
Main Authors: | Don Hayes Jr., Rajni Kant Shukla, Yizi Cheng, Emrah Gecili, Marlena R. Merling, Rhonda D. Szczesniak, Assem G. Ziady, Jason C. Woods, Luanne Hall-Stoodley, Namal P.M. Liyanage, Richard T. Robinson |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical investigation
2022-06-01
|
Series: | JCI Insight |
Subjects: | |
Online Access: | https://doi.org/10.1172/jci.insight.157865 |
Similar Items
-
Forecasting COVID-19 confirmed cases, deaths and recoveries: Revisiting established time series modeling through novel applications for the USA and Italy.
by: Emrah Gecili, et al.
Published: (2021-01-01) -
Pulmonary Nontuberculous Mycobacterial Infection in Infants: A Systematic Review
by: Bai A, et al.
Published: (2021-12-01) -
CFTR-mediated monocyte/macrophage dysfunction revealed by cystic fibrosis proband-parent comparisons
by: Xi Zhang, et al.
Published: (2022-03-01) -
IFN-γ is essential for alveolar macrophage–driven pulmonary inflammation in macrophage activation syndrome
by: Denny K. Gao, et al.
Published: (2021-09-01) -
Acute exacerbation of bronchiectasis secondary to Achromobacter xylosoxidans in a patient with Mycobacterium-Avium Intracellulare infection
by: Kashvi Patel, et al.
Published: (2023-12-01)